Past 90 days
Past 90 days
Past 90 days
Past 90 days
Search
Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
---|---|---|---|---|---|---|---|---|
2025-01-14 | 2025-01-13 | PS Planned sale |
POST LEONARD E Non-Executive Director |
1,000
-100.0%
29.66USD 29,660 |
1,000 -100.0% | 29.66 | USD 100,000 | |
2024-12-17 | 2024-12-16 | S Sale | Non-Executive Director |
700,000
-18.9%
28.00USD 19,600,000 |
700,000 -18.9% | 28.00 | USD 19,600,000 | |
2024-12-17 | 2024-12-16 | PS Planned sale | Non-Executive Director |
1,000
-100.0%
28.84USD 28,840 |
1,000 -100.0% | 28.84 | USD 28,840 | |
2024-12-06 | 2024-12-06 | PS Planned sale | Non-Executive Director |
250
-100.0%
34.98USD 8,744 |
250 -100.0% | 34.98 | USD 8,744 | |
2024-12-06 | 2024-12-06 | PS Planned sale | Non-Executive Director |
750
-75.0%
34.40USD 25,798 |
750 -75.0% | 34.40 | USD 25,798 | |
2024-08-30 | 2024-08-29 | S Sale | Non-Executive Director |
226,245
-5.8%
35.36USD 8,000,023 |
226,245 -5.8% | 35.36 | USD 8,000,023 | |
2024-08-30 | 2024-08-29 | S Sale | Non-Executive Director |
424,210
-42.0%
35.36USD 15,000,066 |
424,210 -42.0% | 35.36 | USD 15,000,066 | |
2024-01-31 | 2024-01-29 | B Purchase |
Chief Medical Officer Officer |
1,315
+inf%
19.00USD 24,985 |
1,315 +inf% | 19.00 | USD 24,985 | |
2024-01-31 | 2024-01-29 | B Purchase | Non-Executive Director |
263,157
+75.0%
19.00USD 4,999,983 |
263,157 +75.0% | 19.00 | USD 4,999,983 | |
2024-01-31 | 2024-01-29 | B Purchase |
CFO & Secretary Officer |
2,000
+inf%
19.00USD 38,000 |
2,000 +inf% | 19.00 | USD 38,000 | |
2024-01-31 | 2024-01-29 | B Purchase |
Decheng Capital Global Life Sciences Fund IV, L.P. Large shareholder |
400,000
+inf%
19.00USD 7,600,000 |
400,000 +inf% | 19.00 | USD 7,600,000 |
// ... existing code ... // ... rest of the file ...